James Friedman, a Wall Street analyst from Susquehanna, has placed a neutral rating on IBM stock for the next year, setting a price target of $303. This forecast suggests a potential upside of approximately 2.6% from the stock's last closing price of around $295.30.
Friedman began coverage of IBM on July 10, highlighting its significant prospects, including a valuation of $65 per share attributed to the company's quantum computing options. He noted impressive performance in IBM's WatsonX AI segment, which has surpassed $12.5 billion in bookings, and emphasized the durable double-digit growth in its software division.
The analyst pointed to the ongoing cycle of IBM's z17 mainframe, which he views as having continued potential for growth. Additionally, he reported that the company is generating $15.7 billion in free cash flow, which adds to the positive outlook for the next twelve months.
Conversely, Friedman raised caution regarding IBM’s Consulting division, which he considers susceptible to disruptions from automation and potential oversupply in the industry. Overall, this sentiment aligns with the findings of other analysts, as an average target of $302.94 was set by 18 analysts surveyed by TipRanks.
Despite these optimistic views, the stock may face challenges breaking through year-to-date resistance. The company's market capitalization stands at approximately $342 billion, and recent concerns about AI stocks contributing to inflation may pose additional risks.
Analysts have also noted that if IBM's stock price falls below its year-to-date support level of around $220, existing targets may not materialize, suggesting a cautious approach moving forward.
This is an informational material and should not be construed as financial advice.
